0001225208-21-003223.txt : 20210219 0001225208-21-003223.hdr.sgml : 20210219 20210219185647 ACCESSION NUMBER: 0001225208-21-003223 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210201 FILED AS OF DATE: 20210219 DATE AS OF CHANGE: 20210219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Strzelecki Angela CENTRAL INDEX KEY: 0001843595 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-04858 FILM NUMBER: 21657720 MAIL ADDRESS: STREET 1: INTERNATIONAL FLAVORS & FRAGRANCES INC. STREET 2: 521 WEST 57TH STREET CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERNATIONAL FLAVORS & FRAGRANCES INC CENTRAL INDEX KEY: 0000051253 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 131432060 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 521 W 57TH ST CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2127655500 MAIL ADDRESS: STREET 1: 521 W 57TH ST CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: VANAMERIGEN HAEBLER INC DATE OF NAME CHANGE: 19680426 4/A 1 doc4a.xml X0306 4/A 2021-02-01 2021-02-03 0000051253 INTERNATIONAL FLAVORS & FRAGRANCES INC IFF 0001843595 Strzelecki Angela 521 WEST 57TH STREET NEW YORK NY 10019 1 President, Pharma Solutions Restricted Stock Units 2021-02-01 4 A 0 1753.0000 A Common Stock 1753.0000 1753.0000 D Restricted Stock Units 2021-02-01 4 A 0 731.0000 A Common Stock 731.0000 2484.0000 D Stock Options (right to buy) 149.6500 2021-02-01 4 A 0 1046.0000 A 2028-02-14 Common Stock 1046.0000 1046.0000 D Stock Options (right to buy) 77.1600 2021-02-01 4 A 0 2588.0000 A 2030-02-18 Common Stock 2588.0000 2588.0000 D Stock Options (right to buy) 123.7600 2021-02-01 4 A 0 2125.0000 A 2021-02-01 2027-02-01 Common Stock 2125.0000 2125.0000 D Stock Options (right to buy) 115.4800 2021-02-01 4 A 0 3481.0000 A 2021-02-01 2022-02-03 Common Stock 3481.0000 3481.0000 D In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. Number of RSUs was misreported due to administrative error. RSUs vest in three equal tranches on each of February 19, 2021, 2022 and 2023, subject to continued employment with IFF. RSUs vest in two equal tranches on each of February 14, 2021 and 2022, subject to continued employment with IFF. Number of Options was misreported due to administrative error. Option is exercisable as of the date of replacement with respect to 696 shares of Common Stock. The Option will become exercisable in respect of the remaining 350 shares of Common Stock on February 15, 2021, subject to continued employment with IFF. In connection with the Transactions, DuPont options were replaced with Options to purchase Common Stock. Options will vest and become exercisable in three equal tranches on each of February 19, 2021, 2022 and 2023, subject to continued employment with IFF. /s/ Nanci Prado, attorney in fact 2021-02-19